# Stimdia Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stimdia-medical

- Industry: Medical Devices & Equipment
- Headquarters: Edina, US
- Website: www.stimdia.com
- Total disclosed funding: $16M
- Latest round: Series B (Jun 15, 2022)
- Investors on record: 2

## About

Based in Minnesota, US, and founded in 2015 out of the University of Minnesota, Stimdia Medical Inc. aims to reduce ventilator weaning times by providing medical equipment and the appropriate medical technologies. In January 2021, Stimdia Medical Inc. raised USD 25 million in series B from new investor Solas BioVentures. The company investors include Draper Triangle Ventures, University of Minnesota Discovery Capital Fund, Piedmont Capital Partners, and Solas Bioventures.

The company is a medical software and equipment company that develops and manufactures solutions designed to minimize ventilator-induced diaphragmatic dysfunction (VIDD) and facilitate weaning from mechanical ventilation to enable improvement in patient outcomes and reduce healthcare treatment costs. The firm offers its device under the brand name pdSTIM SystemTM and its software under the brand name RespiSyncTM. For the patients who are on ventilation for 96 hours or more and having difficulty in weaning pdSTIM SystemTM helps them in weaning from mechanical ventilation by using RespiSyncTM software which aims to coordinate phrenic nerve coordination with physiological diaphragmatic movement.

## Funding rounds

- Series B, Jun 15, 2022, $16M — Magarac Venture Partners, Solas BioVentures

## Investors

- Magarac Venture Partners (https://capitalatlas.ai/funds/magarac-venture-partners) — Series B
- Solas BioVentures (https://capitalatlas.ai/funds/solas-bioventures) — Series B